Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Short term Debt (2017)

Dexcom (DXCM) has disclosed Short term Debt for 8 consecutive years, with $75.0 million as the latest value for Q1 2017.

  • Quarterly Short term Debt rose 4311.76% to $75.0 million in Q1 2017 from the year-ago period, while the trailing twelve-month figure was $75.0 million through Mar 2017, up 4311.76% year-over-year, with the annual reading at $2.3 million for FY2015, 0.0% changed from the prior year.
  • Short term Debt for Q1 2017 was $75.0 million at Dexcom, up from $1.7 million in the prior quarter.
  • The five-year high for Short term Debt was $75.0 million in Q1 2017, with the low at $700000.0 in Q1 2013.
  • Average Short term Debt over 5 years is $7.2 million, with a median of $2.3 million recorded in 2014.
  • The sharpest move saw Short term Debt fell 29.17% in 2016, then soared 4311.76% in 2017.
  • Over 5 years, Short term Debt stood at $2.2 million in 2013, then rose by 4.55% to $2.3 million in 2014, then changed by 0.0% to $2.3 million in 2015, then decreased by 26.09% to $1.7 million in 2016, then skyrocketed by 4311.76% to $75.0 million in 2017.
  • According to Business Quant data, Short term Debt over the past three periods came in at $75.0 million, $1.7 million, and $2.3 million for Q1 2017, Q1 2016, and Q4 2015 respectively.